Table 3.

SARS-CoV-2 Serology Assay Results with B.1.1.7 Clinical Samples.

Sample ID	ARCH IgM (Index)+	Alinity IgM (Index)+	ARCH IgG (Index)+	Alinity IgG (Index)+	ARCH IgG II (AU/mL)+	Alinity IgG II (AU/mL)+	Panbio IgG Result	Days post symptom onset
Patient 1	18.36	18.68	6.76	6.97	13,359.5	11,595.4	Positive	26
Patient 2	1.22	1.26	0.22	0.22	178.5	189.5	Negative	20
Patient 3	11.68	12.05	5.62	6.01	5288.1	6570.1	Positive	19
Patient 4	11.71	11.04	0.8	0.87	149.4	153.7	Negative	25
Patient 5	6.47	6.58	5.29	5.44	5472.9	5468.1	Positive	20
Patient 6	1.31	1.32	6.6	6.58	> 40,000.0	> 40,000.0	Positive	16
Patient 7	14.16	13.51	6.8	6.98	12,034.7	11,191.5	Positive	22
Patient 8	7.41	7.2	6.39	6.36	14,489.9	12,718.3	Positive	21
Patient 9	15.15	14.86	4.73	4.82	2745.6	2603.7	Positive	20
Patient 10	0.03	0.04	0.02	0.02	0.9	0.2	Negative	15
Patient 11	1.27	1.22	0.22	0.23	186.4	186.8	Negative	20
Patient 12	26.79	26.67	6.62	6.6	22,392.8	19,367.7	Positive	23
Patient 13	5.81	6.06	4.31	4.33	1255.4	1183.3	Positive	19
Patient 14	88.25	88.59	6.67	6.42	6811.4	6250	Positive	16
Patient 15	88.27	88.14	6.66	6.58	6815.2	6587.5	Positive	21
Patient 16	88.87	89.11	6.39	6.5	6924.4	6401.6	Positive	18
Patient 17	2.09	2.2	6.23	6.19	1626.4	1630.5	Positive	17
Patient 18	91.31	87.56	6.62	6.55	7459.3	6330	Positive	19
Patient 19	4.56	4.58	7.36	7.31	2345.6	2274.9	Positive	19
Patient 20	4.55	4.61	7.18	7.53	2491.1	2236.1	Positive	20

⁺An index value of ≥1.4 is positive for IgG assays, ≥1.0 is positive for IgM assays, a result of ≥50 AU/ml per mL is positive and <22 AU/mL is not reported in a clinical setting for IgG II assays.